Coherus Biosciences

CHRS

NASDAQHealth Care

Income Statement

Total Revenue$72.8M

Gross Profit$32.97M

Operating Income$-196.52M

EBITDA$50.53M

EBIT$43.86M

Pre-tax Income$-172.66M

Net Income$28.51M

Cash Equivalent$160.67M

Total Debt$321.02M

Book Value$-96.48M

Book Value Per Share-0.84

Return on Equity (ROE)-293.86%

Return on Assets (ROA)+6.36%

Return on Invested Capital (ROI)-56.60%

Net Profit Margin+10.68%

Current Ratio1.21

Quick Ratio0.88

Long-Term Debt / Equity4.18